RVTY Revvity Inc.
Company Analysis
Latest News
Revvity Grows Diagnostics Revenue 11% Organically as AI Shift Gains Traction
Revvity is shifting from a traditional life sciences tools company to a diagnostics-focused, AI-enabled platform. Its Diagnostics segment reported 11% organic...
🟢 Revvity rises 4.1% — Healthcare Stocks Surge on Sector Rotation Out of Tech
With Healthcare (XLV) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector is experiencing a significant...
🟢 Revvity is trading 4.8% up
Revvity is trading 4.8% higher at $164.88 on October 6, 2026, with no fresh company announcement or clearly verified catalyst tied specifically to the intraday...
🟢 Revvity is trading 4.2% up today after announcing CE-IVDR-certified type 1 diabetes screening kit
Revvity is trading 4.2% up at $148.06 after announcing its GSP T1D 3plex kit, a CE-IVDR-certified solution designed to detect children at risk of type 1...
🔴 Revvity is trading 40% down in after-hours trading — catalyst remains unclear
Revvity is trading 40% down at $85.57 after falling sharply in after-hours trading on September 22, 2026; no clear catalyst has been identified. - The...
🟢 Revvity is trading 4.68% up today after stronger diagnostics growth and backlog commentary
Revvity is trading at $146.75, up +4.68% following management’s healthcare-conference commentary on stronger diagnostics growth. - Management also highlighted...
🟢 Revvity is trading 4.61% up today amid healthcare-sector strength
Revvity is trading 4.61% up now at $134.41, amid healthcare-sector strength. - It reached a fresh 52-week high during the September 15, 2026 session. -...
Revvity Sees Major Vote of Confidence as CalSTRS Acquires 12.84% Stake
The California State Teachers Retirement System (CalSTRS) has significantly increased its stake in Revvity Inc., according to a 13F filing reported on...
🔴 Revvity is trading 4.6% down today after XLV ETF's 2.19% decline
Revvity is trading 4.6% down at $121.20 after a broad healthcare-sector selloff. - The XLV ETF was down 2.19% during regular trading. - Concerns include...
Revvity Attracts Massive Wellington Investment, Following Earnings Beat
Wellington Management Group LLP increased its stake in life sciences and diagnostics firm Revvity Inc. by 10,653.8% during the second quarter. The firm...
🟢 Revvity is trading 4% up today on healthcare-sector strength
Revvity is trading 4.01% up now at $131.66, primarily as healthcare-sector strength improves medical-technology sentiment. - Healthcare is up 1.37%, with...
Revvity shares climb 5%, as institutional backing reaches 86%
Revvity Inc. shares rose 5.0% to $119.45 on August 19, 2026. A valuation analysis by GuruFocus suggests the stock is currently overvalued relative to...
🟢 Revvity is trading 4.04% up today amid healthcare sector rotation
Revvity is trading at $124.28, up +4.04%, amid healthcare sector rotation. - Healthcare led broader sector rotation, rising 3.23% during regular trading. - No...
🟢 Revvity is trading 6.1% up today amid sector rotation into healthcare
Revvity is trading 6.1% up at $120.82, with sector rotation into healthcare the strongest current explanation. - It is outperforming the recent August 18,...
🔴 Revvity is trading 4.04% down today on profit-taking after strong earnings
Revvity is trading at $110.60 (-4.04%) as investors lock in gains following a significant post-earnings rally. • The company reported Q2 revenue of $730...
Revvity's second quarter revenue of $730M and adj. EPS of $1.41 beat estimates, leading to a raised full-year outlook.
Revvity reported second quarter 2026 results that exceeded analyst expectations, driven by strong performance in its Diagnostics segment. The company posted...
Revvity Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Analysts expect Revvity to report Q2 2026 revenue of approximately $703.2 million and adjusted EPS of $1.23, with the stock currently trading near $112.52...
🟢 Revvity is trading 4.7% up today as it recovers from recent weakness
Revvity is trading at $111.42 (4.7%) up today, bouncing back from yesterday’s decline despite a lack of fresh, stock-specific news or major announcements...
Revvity Surges 8% on Rosy Outlook and Lower Debt — But Can a Leaner Balance Sheet Justify a Premium Valuation?
Shares of Revvity (RVTY) vaulted 8.1% to $120.11 on July 14 after S&P Global Ratings upgraded the company's outlook, citing improving leverage and strong cash...
🟢 Revvity is trading 8.1% up today after outlook upgrade and solid cash flow expectations
Revvity is trading 8.1% up at $120.11 following an outlook upgrade and solid cash flow expectations highlighted by S&P Global. • The move builds on momentum...